Two Day Pharmaceutical Effective Technology Transfer Course (London, United Kingdom - May 21-22, 2019)
Dublin, May 20, 2019 (GLOBE NEWSWIRE) -- The "Effective Technology Transfer" conference has been added to ResearchAndMarkets.com's offering.
This event will give participants the tools to help guide them through achieving successful transfers. It is applicable to those making transfers from development to commercial, from commercial to commercial, for scale up, analytical methods or for virtual' companies.
Technology Transfer (TT) is an increasingly important part of the pharmaceutical industry, with companies expanding the use of third parties for both development and manufacture. There are few formal guidelines around this subject, but regulators expect companies to get it right, for both internal and external transfers. Poorly run transfers can be costly and impact product quality, whereas well-run transfers bring business benefits and assure product quality.
Benefits of attending:
- Understand that technology transfer (TT) is part of the product lifecycle, supported by the pharmaceutical quality system
- Know where TT is covered in ICH, FDA, EU, WHO and PIC/S guidelines
- Learn the key steps for successful transfers
- Know how to engage sending and receiving units (SU and RU) for TT
- Understand how product and process understanding enables TT
- Apply tools such as quality risk management and clarify risks involved in TT
- Understand how change should be handled, eg facility and equipment differences between SU and RU; scale-up
- Gain understanding of how analytical method transfers are an integral part of TT
- Recognise how TT impacts a wide range of companies from innovative to generic, including development, manufacturing, major corporations and virtual' companies
- Realise how significant business benefits emerge from successful TT
Who Should Attend:
This seminar will be of particular interest to all those from the pharmaceutical industry working in:
- Development
- Manufacturing
- Engineering
- Quality
Personnel from the pharmaceutical and biopharmaceutical industry with the following background:
- Pharmacists
- Scientists
- Engineers
- Quality assurance professionals
- Quality control managers
- Late stage product and process development engineers, scientists, pharmacists
- Technology scale up and transfer managers
- Validation and quali cation specialists
- Risk management specialists
- Operation managers
Agenda:
Day 1:
Regulatory guidance and business drivers for TT
ICH Q10
Exercise one
- What makes a successful TT?
Industry guidance for Sending and Receiving Units (SU and RU)
Knowledge
- What do SU and RU need?
Exercise two
- Knowledge
Science and risk-based approaches - Part one
Science and risk-based approaches - Part two
- Equipment and utilities
Exercise three
- Equipment at SU and RU
Quality risk management
Day 2:
Project management steps for TT - Part one
Exercise four
- Case study - Fishbone for TT
Project management steps for TT - Part two
Exercise five
- Case study - Organising TT
Validation and qualification
Exercise six
- SU and RU
Analytical method transfer - Part one
Analytical method transfer - Part two
Enabling successful TT - Softer' issues
For more information about this conference visit https://www.researchandmarkets.com/r/568cq4
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Pharmaceutical Manufacturing
Distribution channels: Banking, Finance & Investment Industry, Technology
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release